We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Mandatory Surveillance of MRSA, MSSA and Gram-negative bacteraemia and Clostridioides difficile infection: May 2021 to May 2022
Mandatory Surveillance of MRSA, MSSA and Gram-negative bacteraemia and Clostridioides difficile infection: March 2021 to March 2022
Mandatory surveillance of healthcare associated infections (HCAI); MRSA, MSSA, and Escherichia coli (E. coli) bacteraemia and Clostridium difficile (C. difficile) infection.
Mandatory Surveillance of MRSA, MSSA and Gram-negative bacteraemia and Clostridioides difficile infection: February 2021 to February 2022
Mandatory surveillance of healthcare associated infections (HCAI); MRSA, MSSA and Gram-negative bacteraemia (Escherichia coli (E. coli), Pseudomonas aeruginosa (P. aeruginosa), Klebsiella species (Klebsiella. spp.), and Clostridioides difficile (C. difficile) infection. Annual data and epidemiological commentary for the financial year April...
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).